Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-01T02:53:17.529Z Has data issue: false hasContentIssue false

Chapter 28 - Squamous cell carcinoma of the lung

Published online by Cambridge University Press:  05 June 2014

By
Douglas B. Flieder  and
Elisabeth Brambilla
Edited by
Philip Hasleton  and
Douglas B. Flieder
Philip Hasleton
Affiliation:
University of Manchester
Douglas B. Flieder
Affiliation:
Fox Chase Cancer Center, Philadelphia
Get access

Summary

Introduction

Although squamous cell carcinoma (SCC) of the lung has been supplanted by adenocarcinoma as the most common histological type of non-small cell carcinoma (NSCLC) in pockets of the developed world, this carcinoma is by no means a rare entity. In fact, incidence rates for SCC in men and women still surpass those of adenocarcinoma in several European countries. The tobacco-related malignancy probably represents at least 30% of newly diagnosed lung cancers worldwide, but exact figures are difficult to ascertain. Since SCC has higher resectability and perhaps cure rates than other lung carcinomas, this subtype is overrepresented in surgical series and underrepresented in autopsy series. Basic pathogenetic mechanisms have been known for decades and our ability to monitor high-risk patients has greatly improved (see Chapters 23 and 24). Given the recent emphasis on distinguishing SCC from adenocarcinoma for therapeutic reasons, this chapter will present our current understanding of this carcinoma and highlight recent developments in diagnosis.

Classification and cell of origin

The 2004 World Health Organization (WHO) Classification is the globally recognized lung tumor classification scheme. The classification is descriptive and almost entirely based on light microscopic features. Squamous cell carcinoma is a malignant epithelial tumor with keratinization and/or intercellular bridges. Although many morphological variants have been described, the WHO limits the classification to papillary, clear cell, small cell, and basaloid subtypes (Table 1). Squamous cell carcinoma may also be combined with adenocarcinoma or small cell carcinoma (SCLC) in addition to other malignancies. A diagnosis of adenosquamous carcinoma requires that at least 10% of the SCC tumor features either an unequivocal glandular component or alternatively at least 10% of an obvious adenocarcinoma contains unequivocal keratinization or intercellular bridges. Of note, rare mucin vacuoles can be seen in typical SCC. Squamous cell carcinoma seen in association with SCLC is termed combined SCLC (see Chapter 31).

Type
Chapter
Information
Spencer's Pathology of the Lung , pp. 1093 - 1113
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Yang, P, Allen, MS, Aubry, MC, et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005;128:452–62.CrossRefGoogle Scholar
Stojsic, J, Radojicic, J, Markovic, J, et al. Gender and age trends of histological types of lung cancer in a 20-year period: pathological perspective. J BUON 2010;15:136–40.Google Scholar
Carter, D.Squamous cell carcinoma of the lung: an update. Semin Diagn Pathol 1985;2:226–34.Google ScholarPubMed
Ferlay, J, Parkin, DM, Steliarova-Foucher, E.Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765–81.CrossRefGoogle ScholarPubMed
Johnston, WW.Histologic and cytologic patterns of lung cancer in 2,580 men and women over a 15-year period. Acta Cytol 1988;32:163–8.Google Scholar
Travis, WD, Brambilla, E, Müller-Hermelink, HK, Harris, CC.Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004.Google Scholar
Fukushima, M, Homma, K, Hashimoto, T, Suzuki, R, Koike, T.Histologically unique case of combined small cell and squamous cell carcinoma in a polypoid bronchial tumor. Pathol Int 2005;55:785–91.CrossRefGoogle Scholar
Gatter, KC, Dunnill, MS, Heryet, A, Mason, DY.Human lung tumours: does intermediate filament co-expression correlate with other morphological or immunocytochemical features?Histopathology 1987;11:705–14.CrossRefGoogle ScholarPubMed
Copin, MC, Devisme, L, Buisine, MP, et al. From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes. Int J Cancer 2000;86:162–8.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
McDowell, EM, McLaughlin, JS, Merenyl, DK, et al. The respiratory epithelium. V. Histogenesis of lung carcinomas in the human. J Natl Cancer Inst 1978;61:587–606.Google ScholarPubMed
Trump, BF, McDowell, EM, Glavin, F, et al. The respiratory epithelium. III. Histogenesis of epidermoid metaplasia and carcinoma in situ in the human. J Natl Cancer Inst 1978;61:563–75.Google ScholarPubMed
Yamamoto, M, Shimokata, K, Nagura, H.Immunoelectron microscopic study on the histogenesis of epidermoid metaplasia in respiratory epithelium. Am Rev Respir Dis 1987;135:713–8.Google ScholarPubMed
Tobacco, . In Stewart, BW, Kleihues, P, International Agency for Research on Cancer, eds. World Cancer Report. Lyon: IARC Press, 2003. pp. 22–8.Google Scholar
Hecht, SS.Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194–210.CrossRefGoogle ScholarPubMed
Tobacco smoking. In IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Lyon: IARC, 1986.Google Scholar
Peto, R, Lopez, AD, Boreham, J, Thun, M, Heath, CW Jr.Mortality from Smoking in Developed Countries 1950–2000: Indirect Estimates from National Vital Statistics. Oxford: Oxford University Press, 1994.Google Scholar
Brouchet, L, Valmary, S, Dahan, M, et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005;92:743–6.CrossRefGoogle ScholarPubMed
Clavel, CE, Nawrocki, B, Bosseaux, B, et al. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 2000;88:1347–52.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Cook, JR, Hill, DA, Humphrey, PA, Pfeifer, JD, El-Mofty, SK.Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 2000;13:914–8.CrossRefGoogle ScholarPubMed
Guillou, L, Sahli, R, Chaubert, P, et al. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol 1991;15:891–8.CrossRefGoogle Scholar
Jain, N, Singh, V, Hedau, S, et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005;128:3999–4007.CrossRefGoogle ScholarPubMed
Miyagi, J, Tsuhako, K, Kinjo, T, Iwamasa, T, Hirayasu, T.Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 2000;53:676–84.CrossRefGoogle ScholarPubMed
Syrjanen, KJ.HPV infections and lung cancer. J Clin Pathol 2002;55:885–91.CrossRefGoogle ScholarPubMed
Welt, A, Hummel, M, Niedobitek, G, Stein, H.Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. J Pathol 1997;181:276–80.3.0.CO;2-L>CrossRefGoogle Scholar
Yousem, SA, Ohori, NP, Sonmez-Alpan, E.Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992;69:693–7.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Balsara, BR, Testa, JR.Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877–83.CrossRefGoogle ScholarPubMed
Petersen, I, Bujard, M, Petersen, S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997;57:2331–5.Google ScholarPubMed
Gebhart, E, Liehr, T.Patterns of genomic imbalances in human solid tumors (Review). Int J Oncol 2000;16:383–99.Google Scholar
Foster, NA, Banerjee, AK, Xian, J, et al. Somatic genetic changes accompanying lung tumor development. Genes Chromosomes Cancer 2005;44:65–75.CrossRefGoogle ScholarPubMed
Hussenet, T, Dali, S, Exinger, J, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010;5:e8960.CrossRefGoogle ScholarPubMed
Hussenet, T, du Manoir, S.SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 2010;9:1480–6.CrossRefGoogle ScholarPubMed
Massion, PP, Kuo, WL, Stokoe, D, et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res 2002;62:3636–40.Google ScholarPubMed
Massion, PP, Zou, Y, Uner, H, et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS One 2009;4:e5611.CrossRefGoogle ScholarPubMed
Pelosi, G, Del Curto, B, Trubia, M, et al. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res 2007;13:1995–2004.CrossRefGoogle ScholarPubMed
Yokoi, S, Yasui, K, Iizasa, T, et al. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 2003;9:4705–13.Google ScholarPubMed
Yuan, P, Kadara, H, Behrens, C, et al. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 2010;5:e9112.CrossRefGoogle ScholarPubMed
Samuels, Y, Ericson, K.Oncogenic PI3K and its role in cancer. Curr Opin Oncol 2006;18:77–82.CrossRefGoogle Scholar
Kendall, J, Liu, Q, Bakleh, A, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 2007;104:16663–8.CrossRefGoogle ScholarPubMed
Burbee, DG, Forgacs, E, Zochbauer-Muller, S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691–9.CrossRefGoogle ScholarPubMed
Verri, C, Roz, L, Conte, D, et al. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med 2009;179:396–401.CrossRefGoogle ScholarPubMed
Mertens, F, Johansson, B, Hoglund, M, Mitelman, F.Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765–80.Google ScholarPubMed
Chujo, M, Noguchi, T, Miura, T, et al. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 2002;38:23–9.CrossRefGoogle ScholarPubMed
Petersen, S, Aninat-Meyer, M, Schluns, K, et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 2000;82:65–73.CrossRefGoogle ScholarPubMed
Devesa, SS, Bray, F, Vizcaino, AP, Parkin, DM.International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294–9.CrossRefGoogle ScholarPubMed
Subramanian, J, Morgensztern, D, Goodgame, B, et al. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol 2010;5:23–8.CrossRefGoogle Scholar
Alberg, AJ, Brock, MV, Samet, JM.Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005;23:3175–85.CrossRefGoogle Scholar
Beckles, MA, Spiro, SG, Colice, GL, Rudd, RM.Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003;123:97S–104S.CrossRefGoogle ScholarPubMed
Patel, AM, Peters, SG.Clinical manifestations of lung cancer. Mayo Clin Proc 1993;68:273–7.CrossRefGoogle ScholarPubMed
Nagamoto, N, Saito, Y, Ohta, S, et al. Relationship of lymph node metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer. Am J Surg Pathol 1989;13:1009–13.CrossRefGoogle ScholarPubMed
Nagamoto, N, Saito, Y, Suda, H, et al. Relationship between length of longitudinal extension and maximal depth of transmural invasion in roentgenographically occult squamous cell carcinoma of the bronchus (nonpolypoid type). Am J Surg Pathol 1989;13:11–20.CrossRefGoogle Scholar
Saito, Y, Nagamoto, N, Ota, S, et al. Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1992;104:401–7.Google ScholarPubMed
Usuda, K, Saito, Y, Nagamoto, N, et al. Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 1993;106:1098–103.Google ScholarPubMed
Funai, K, Yokose, T, Ishii, G, et al. Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 2003;27:978–84.CrossRefGoogle ScholarPubMed
Sakurai, H, Asamura, H, Watanabe, S, Suzuki, K, Tsuchiya, R.Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann Thorac Surg 2004;78:222–7.CrossRefGoogle ScholarPubMed
Tomashefski, JF Jr, Connors, AF Jr, Rosenthal, ES, Hsiue, IL.Peripheral vs central squamous cell carcinoma of the lung. A comparison of clinical features, histopathology, and survival. Arch Pathol Lab Med 1990;114:468–74.Google Scholar
Oliver, TB, Stevenson, AJ, Gillespie, IN.Pulmonary artery pseudoaneurysm due to bronchial carcinoma. Br J Radiol 1997;70:950–1.CrossRefGoogle ScholarPubMed
Arcasoy, SM, Jett, JR.Superior pulmonary sulcus tumors and Pancoast's syndrome. N Engl J Med 1997;337:1370–6.CrossRefGoogle ScholarPubMed
Goldberg, M, Gupta, D, Sasson, AR, et al. The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up. Ann Thorac Surg 2005;79:1174–9.CrossRefGoogle ScholarPubMed
Hagan, MP, Choi, NC, Mathisen, DJ, et al. Superior sulcus lung tumors: impact of local control on survival. J Thorac Cardiovasc Surg 1999;117:1086–94.CrossRefGoogle ScholarPubMed
Komaki, R, Roth, JA, Walsh, GL, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2000;48:347–54.CrossRefGoogle ScholarPubMed
Rusch, VW, Parekh, KR, Leon, L, et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 2000;119:1147–53.CrossRefGoogle ScholarPubMed
Colby, TV, Koss, MN, Travis, WD.Carcinoma of the lung: clinical and radiographic aspects, spread, staging, management, and prognosis. In Colby, TV, Koss, MN, Travis, WD, eds. Tumors of the Lower Respiratory Tract, 3rd ed. Washington DC: Armed Forces Institute of Pathology, 1995. pp. 107–34.Google Scholar
Coggeshall, J, Merrill, W, Hande, K, Des, Prez R.Implications of hypercalcemia with respect to diagnosis and treatment of lung cancer. Am J Med 1986;80:325–8.CrossRefGoogle ScholarPubMed
Green, KB, Silverstein, RL.Hypercoagulability in cancer. Hematol Oncol Clin North Am 1996;10:499–530.CrossRefGoogle Scholar
Martin, TJ, Moseley, JM, Gillespie, MT.Parathyroid hormone-related protein: biochemistry and molecular biology. Crit Rev Biochem Mol Biol 1991;26:377–95.CrossRefGoogle ScholarPubMed
Sridhar, KS, Lobo, CF, Altman, RD.Digital clubbing and lung cancer. Chest 1998;114:1535–7.CrossRefGoogle ScholarPubMed
Goldstraw, P.Lung. In Edge, S, Byrd, D, Compton, C, eds. AJCC Cancer Staging Manual, 7th ed. New York: Springer-Verlag, 2010. pp. 252–70.Google Scholar
Goldstraw, P, ed. International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology. Orange Park: Editorial Rx Press, 2009.
Jain, NK, Madan, A, Sharma, TN, et al. Bronchogenic carcinoma. A study of 109 cases. J Assoc Physicians India 1989;37:379–82.Google ScholarPubMed
Rosado-de-Christenson, ML, Templeton, PA, Moran, CA.Bronchogenic carcinoma: radiologic-pathologic correlation. Radiographics 1994;14:429–46; quiz 47–8.CrossRefGoogle ScholarPubMed
Kaneda, M, Tarukawa, T, Watanabe, F, et al. Clinical features of primary lung cancer adjoining pulmonary bulla. Interact Cardiovasc Thorac Surg 2010;10:940–4.CrossRefGoogle ScholarPubMed
O'Connell, RS, McLoud, TC, Wilkins, EW.Superior sulcus tumor: radiographic diagnosis and workup. AJR Am J Roentgenol 1983;140:25–30.CrossRefGoogle ScholarPubMed
Urschel, HC Jr.Superior pulmonary sulcus carcinoma. Surg Clin North Am 1988;68:497–509.CrossRefGoogle ScholarPubMed
Nakayama, J, Miyasaka, K, Omatsu, T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010;34:1–8.CrossRefGoogle ScholarPubMed
Freudenberg, LS, Rosenbaum, SJ, Beyer, T, Bockisch, A, Antoch, G.PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Thorac Surg Clin 2010;20:25–30.CrossRefGoogle ScholarPubMed
Vansteenkiste, JF, Stroobants, SG, Dupont, PJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998;25:1495–501.CrossRefGoogle ScholarPubMed
Cerfolio, RJ, Ojha, B, Bryant, AS, et al. The accuracy of integrated PET-CT compared with dedicated PEt alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017–23; discussion -23.CrossRefGoogle ScholarPubMed
Yu, HM, Liu, YF, Hou, M, et al. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer. Eur J Radiol 2009;72:104–13.CrossRefGoogle ScholarPubMed
Ak, I, Sivrikoz, MC, Entok, E, Vardareli, E.Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Eur J Cardiothorac Surg 2010;37:792–6.CrossRefGoogle ScholarPubMed
Subedi, N, Scarsbrook, A, Darby, M, et al. The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer 2009;64:301–7.CrossRefGoogle ScholarPubMed
Aristei, C, Falcinelli, L, Palumbo, B, Tarducci, R.PET and PET-CT in radiation treatment planning for lung cancer. Expert Rev Anticancer Ther 2010;10:571–84.CrossRefGoogle ScholarPubMed
Yousem, SA.Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling. Hum Pathol 2009;40:861–7.CrossRefGoogle ScholarPubMed
Boucher, LD, Yoneda, K.The expression of trophoblastic cell markers by lung carcinomas. Hum Pathol 1995;26:1201–6.CrossRefGoogle ScholarPubMed
Dirnhofer, S, Freund, M, Rogatsch, H, Krabichler, S, Berger, P.Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha). Hum Pathol 2000;31:966–72.CrossRefGoogle Scholar
Hiroshima, K, Iyoda, A, Toyozaki, T, et al. Alpha-fetoprotein-producing lung carcinoma: report of three cases. Pathol Int 2002;52:46–53.CrossRefGoogle ScholarPubMed
Howe, MC, Chapman, A, Kerr, K, et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 2005;46:195–201.CrossRefGoogle ScholarPubMed
Nicholson, AG, Gonzalez, D, Shah, P, et al. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 2010;5:436–41.CrossRefGoogle ScholarPubMed
Pelosi, G, Pasini, F, Sonzogni, A, et al. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer 2003;97:2487–97.CrossRefGoogle ScholarPubMed
Visscher, DW, Zarbo, RJ, Trojanowski, JQ, Sakr, W, Crissman, JD.Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study. Mod Pathol 1990;3:508–12.Google ScholarPubMed
Bishop, JA, Benjamin, H, Cholakh, H, et al. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010;16:610–9.CrossRefGoogle ScholarPubMed
Kim, DH, Kwon, MS.Role of fine needle aspiration cytology, cell block preparation and CD63, P63 and CD56 immunostaining in classifying the specific tumor type of the lung. Acta Cytol 2010;54:55–9.CrossRefGoogle ScholarPubMed
Loo, PS, Thomas, SC, Nicolson, MC, Fyfe, MN, Kerr, KM.Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol 2010;5:442–7.CrossRefGoogle ScholarPubMed
Rossi, G, Pelosi, G, Graziano, P, Barbareschi, M, Papotti, M.A reevaluation of the clinical significance of histological subtyping of non – small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol 2009;17:206–18.CrossRefGoogle ScholarPubMed
Mukhopadhyay, S, Katzenstein, AL.Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011;35:15–25.CrossRefGoogle Scholar
Monica, V, Ceppi, P, Righi, L, et al. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 2009;22:709–17.CrossRefGoogle ScholarPubMed
Savci-Heijink, CD, Kosari, F, Aubry, MC, et al. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol 2009;174:1629–37.CrossRefGoogle Scholar
Del Vescovo, V, Cantaloni, C, Cucino, A, et al. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol 2011;35:268–75.CrossRefGoogle Scholar
Bombi, JA, Martinez, A, Ramirez, J, et al. Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature. Ultrastruct Pathol 2002;26:211–8.CrossRefGoogle ScholarPubMed
Dingemans, KP, Mooi, WJ.Ultrastructure of squamous cell carcinoma of the lung. Pathol Annu 1984;19 Pt 1:249–73.
Hammar, S.The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms. Clin Lab Med 1987;7:1–30.Google ScholarPubMed
Hammar, SP, Bolen, JW, Bockus, D, Remington, F, Friedman, S.Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct Pathol 1985;9:283–318.CrossRefGoogle ScholarPubMed
Sidhu, GS.The ultrastructure of malignant epithelial neoplasms of the lung. Pathol Annu 1982;17 (Pt 1):235–66.Google ScholarPubMed
Sorhaug, S, Steinshamn, S, Haaverstad, R, et al. Expression of neuroendocrine markers in non-small cell lung cancer. APMIS 2007;115:152–63.CrossRefGoogle ScholarPubMed
Nakanishi, K, Kawai, T, Suzuki, M, Torikata, C.Bronchogenic squamous cell carcinomas with invasion along alveolar walls. Histopathology 1996;29:363–8.CrossRefGoogle ScholarPubMed
Dingemans, KP, Mooi, WJ.Invasion of lung tissue by bronchogenic squamous-cell carcinomas: interaction of tumor cells and lung parenchyma in the tumor periphery. Int J Cancer 1986;37:11–9.CrossRefGoogle ScholarPubMed
Franklin, WA, Veve, R, Hirsch, FR, Helfrich, BA, Bunn, PA Jr.Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 2002;29:3–14.CrossRefGoogle ScholarPubMed
Kaye, FJ.RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908–14.CrossRefGoogle ScholarPubMed
Brambilla, E, Moro, D, Gazzeri, S, Brambilla, C.Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 1999;188:351–60.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Jeanmart, M, Lantuejoul, S, Fievet, F, et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 2003;9:2195–203.Google ScholarPubMed
Wang, Y, Zhang, D, Zheng, W, et al. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer 2008;112:1325–36.CrossRefGoogle ScholarPubMed
Toyooka, S, Toyooka, KO, Maruyama, R, et al. DNA methylation profiles of lung tumors. Mol Cancer Ther 2001;1:61–7.Google ScholarPubMed
Toyooka, S, Maruyama, R, Toyooka, KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer 2003;103:153–60.CrossRefGoogle ScholarPubMed
Van Den Broeck, A, Brambilla, E, Moro-Sibilot, D, et al. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin Cancer Res 2008;14:7237–45.CrossRefGoogle ScholarPubMed
Brambilla, E, Gazdar, A.Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J 2009;33:1485–97.CrossRefGoogle ScholarPubMed
Lu, J, Getz, G, Miska, EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834–8.CrossRefGoogle ScholarPubMed
Mascaux, C, Laes, JF, Anthoine, G, et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 2009;33:352–9.CrossRefGoogle ScholarPubMed
Emens, LA, Jaffee, EM.To live or not to live: that depends on GAGE?Cancer Biol Ther 2002;1:388–90.CrossRefGoogle ScholarPubMed
Sato, T, Murakumo, Y, Hagiwara, S, et al. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Pathol Int 2007;57:719–24.CrossRefGoogle ScholarPubMed
Hou, J, Aerts, J, den Hamer, B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010;5:e10312.CrossRefGoogle ScholarPubMed
Vachani, A, Nebozhyn, M, Singhal, S, et al. A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma. Clin Cancer Res 2007;13:2905–15.CrossRefGoogle ScholarPubMed
Sandler, AB, Schiller, JH, Gray, R, et al. Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab. J Clin Oncol 2009;27:1405–12.CrossRefGoogle Scholar
Ciuleanu, T, Brodowicz, T, Zielinski, C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 2009;374:1432–40.CrossRefGoogle ScholarPubMed
Johnson, DH, Fehrenbacher, L, Novotny, WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184–91.CrossRefGoogle ScholarPubMed
Scagliotti, G, Hanna, N, Fossella, F, et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. Oncologist 2009;14:253–63.CrossRefGoogle ScholarPubMed
Scagliotti, GV, Parikh, P, von Pawel, J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543–51.CrossRefGoogle ScholarPubMed
Wallace, WA.The challenge of classifying poorly differentiated tumours in the lung. Histopathology 2009;54:28–42.CrossRefGoogle ScholarPubMed
Dorfman, DM, Shahsafaei, A, Chan, JK.Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 1997;21:936–40.CrossRefGoogle Scholar
Kornstein, MJ, Rosai, J.CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol 1998;109:722–6.CrossRefGoogle ScholarPubMed
Pomplun, S, Wotherspoon, AC, Shah, G, et al. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology 2002;40:152–8.CrossRefGoogle ScholarPubMed
Tateyama, H, Eimoto, T, Tada, T, et al. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol 1999;111:235–40.CrossRefGoogle ScholarPubMed
Geurts, TW, Nederlof, PM, van den Brekel, MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?Clin Cancer Res 2005;11:6608–14.CrossRefGoogle ScholarPubMed
Girard, N, Ostrovnaya, I, Lau, C, et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers. Clin Cancer Res 2009;15:5184–90.CrossRefGoogle ScholarPubMed
Leong, PP, Rezai, B, Koch, WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1998;90:972–7.CrossRefGoogle ScholarPubMed
Talbot, SG, Estilo, C, Maghami, E, et al. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res 2005;65:3063–71.CrossRefGoogle ScholarPubMed
Brundage, MD, Davies, D, Mackillop, WJ.Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037–57.CrossRefGoogle ScholarPubMed
Gomez de la, A, Lopez-Encuentra, A, Ferrando, P.Heterogeneity of prognostic profiles in non-small cell lung cancer: too many variables but a few relevant. Eur J Epidemiol 2005;20:907–14.CrossRefGoogle Scholar
Pelletier, MP, Edwardes, MD, Michel, RP, Halwani, F, Morin, JE.Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001;44:180–8.Google ScholarPubMed
Gail, MH, Eagan, RT, Feld, R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 1984;54:1802–13.3.0.CO;2-4>CrossRefGoogle Scholar
Harpole, DH Jr, Herndon, JE 2nd, Young, WG Jr, Wolfe, WG, Sabiston, DC Jr.Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787–96.3.0.CO;2-Q>CrossRefGoogle Scholar
Ichinose, Y, Yano, T, Asoh, H, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg 1995;110:601–5.CrossRefGoogle ScholarPubMed
Martini, N, Burt, ME, Bains, MS, et al. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992;54:460–5; discussion 6.CrossRefGoogle ScholarPubMed
Martini, N, Flehinger, BJ.The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037–49.CrossRefGoogle ScholarPubMed
Nesbitt, JC, Putnam, JB Jr, Walsh, GL, Roth, JA, Mountain, CF.Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995;60:466–72.CrossRefGoogle ScholarPubMed
Padilla, J, Calvo, V, Penalver, JC, Sales, G, Morcillo, A.Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997;63:324–6.CrossRefGoogle ScholarPubMed
Gasinska, A, Kolodziejski, L, Niemiec, J, Dyczek, S.Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer. Lung Cancer 2005;49:171–9.CrossRefGoogle ScholarPubMed
Puri, V, Garg, N, Engelhardt, EE, et al. Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg 2010;89:1053–9.CrossRefGoogle Scholar
Hu, Z, Chen, X, Zhao, Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721–6.CrossRefGoogle Scholar
Landi, MT, Zhao, Y, Rotunno, M, et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010;16:430–41.CrossRefGoogle ScholarPubMed
Sherwin, RP, Laforet, EG, Strieder, JW.Exophytic endobronchial carcinoma. J Thorac Cardiovasc Surg 1962;43:716–30.Google ScholarPubMed
Dulmet-Brender, E, Jaubert, F, Huchon, G.Exophytic endobronchial epidermoid carcinoma. Cancer 1986;57:1358–64.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
Katzenstein, AL, Prioleau, PG, Askin, FB.The histologic spectrum and significance of clear-cell change in lung carcinoma. Cancer 1980;45:943–7.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Churg, A, Johnston, WH, Stulbarg, M.Small cell squamous and mixed small cell squamous – small cell anaplastic carcinomas of the lung. Am J Surg Pathol 1980;4:255–63.CrossRefGoogle ScholarPubMed
Wang, BY, Gil, J, Kaufman, D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 2002;33:921–6.CrossRefGoogle ScholarPubMed
Wu, M, Wang, B, Gil, J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696–702.Google ScholarPubMed
Zhang, H, Liu, J, Cagle, PT, et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol 2005;18:111–8.CrossRefGoogle ScholarPubMed
Cakir, E, Demirag, F, Ucoluk, GO, Kaya, S, Memis, L.Basaloid squamous cell carcinoma of the lung: a rare tumour with a rare clinical presentation. Lung Cancer 2007;57:109–11.CrossRefGoogle ScholarPubMed
Moro-Sibilot, D, Lantuejoul, S, Diab, S, et al. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J 2008;31:854–9.CrossRefGoogle ScholarPubMed
Brambilla, E, Moro, D, Veale, D, et al. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 1992;23:993–1003.CrossRefGoogle ScholarPubMed
Dugan, JM.Cytologic diagnosis of basal cell (basaloid) carcinoma of the lung. A report of two cases. Acta Cytol 1995;39:539–42.Google Scholar
Kim, MJ, Ha, SY, Kim, NR, et al. Aspiration cytology features of pulmonary basaloid carcinoma. Cytopathology 2009;20:336–9.CrossRefGoogle ScholarPubMed
Ma, TK.Fine needle aspiration cytodiagnosis of basaloid-squamous cell carcinoma metastatic to a cervical lymph node. Acta Cytol 1993;37:977–9.Google ScholarPubMed
Sturm, N, Lantuejoul, S, Laverriere, MH, et al. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 2001;32:918–25.CrossRefGoogle ScholarPubMed
Lin, O, Harkin, TJ, Jagirdar, J.Basaloid-squamous cell carcinoma of the bronchus. Report of a case with review of the literature. Arch Pathol Lab Med 1995;119:1167–70.Google ScholarPubMed
Morice, WG, Ferreiro, JA.Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol 1998;29:609–12.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×